Susmed (4263.T) Stock Price

Susmed Price

CLOSED
375.00
​
Market closed

Over the last 6 years Susmed grew revenue by 55.7% annually, reaching 497.21 M JPY. For Susmed, the net margin of -77.0% is down versus -73.7% a few years ago.

Susmed stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Susmed business model & stock analysis

Susmed Inc, based in Chuo-Ku, Tokyo, operates in the Health Care sector with a focus on developing therapeutic applications. The company, listed on 24 December 2021, employs 33 full-time staff and functions through two segments: DTx Product, creating software for treating conditions like insomnia and chronic kidney disease, and DTx Platform, offering clinical trial systems and machine learning analysis services for DTx development support.

Frequently asked questions about Susmed

5 analysts currently rate the Susmed stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Susmed share trades at 2.12 EUR (375.00 JPY).

The revenue of Susmed is 497.21 M JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of Susmed is -382.69 M JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Susmed is currently -16.54. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Susmed stock.

The price-to-sales ratio (P/S) of Susmed is currently 12.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Susmed stock.

The Eulerpool Quality Score for Susmed is 2/10.

The ISIN of Susmed is JP3319150003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Susmed is 4263.T. The ticker symbol is used to trade Susmed shares on the stock exchange.

Fair ValueTerminal
352.50 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
15.07 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website susmed.co.jp
Country
Currency
JPY
Initial public offering
Dec 24, 2021
ISIN
JP3319150003
Cusip
J7844R105
Market capitalization
6.33 B JPYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2027
-42.15
P/Ee 2028
170.45
P/Ee 2029
2.80
P/Ee 2030
2.23
P/Se
6.03
EV/EBIT
—
P/B Ratio
1.55
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-9.40 %
Last updated Oct 19, 2026, 5:05 PM

Susmed Peer Group

Susmed FIGI

4263:JP · BBG00TS9P4Z24263:JT · BBG013NG3R084263:JJ · BBG013NG3R994263:JE · BBG013NG3RD44263:JI · BBG013NG3RF24263:JU · BBG013NG3RG14263:JW · BBG013NG3RH04263:JV · BBG0193RDNT0

All fundamentals and in-depth analysis of Susmed

Our stock analysis for Susmed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Susmed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.